Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 1, 2003, Pages 217-222

  Drexler, Ingo ^a   Staib, Caroline ^a   Kastenmüller, Wolfgang ^a   Stevanović, Stefan ^b   Schmidt, Burkhard ^a   Lemonnier, François A ^c   Rammensee, Hans Georg ^b   Busch, Dirk H ^a   Bernhard, Helga ^a   Erfle, Volker ^a   Sutter, Gerd ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Unite d'Immun Cellulaire Antivirale   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HLA A ANTIGEN; SMALLPOX VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SPECIFICITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; IMMUNIZATION; IMMUNOGENICITY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; SMALLPOX VIRUS; T LYMPHOCYTE; TRANSGENIC MOUSE; VACCINIA VIRUS; VIRUS IDENTIFICATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; EPITOPES; HLA-A ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SMALLPOX VACCINE; T-LYMPHOCYTES; VACCINIA VIRUS;

ANIMALIA; ANKARA; DNA VIRUSES; MUS MUSCULUS; ORTHOPOX VIRUS; POXVIRIDAE; VACCINIA; VACCINIA VIRUS; VARIOLA; VARIOLA VIRUS;

EID: 0037422549     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.262668999     Document Type: Article

References (33)

1. Lane, H. C., Montagne, J. L. & Fauci, A. S. (2001) Nat. Med. 7, 1271-1273.
2. Gani, R. & Leach, S. (2001) Nature 414, 748-751.
3. Fenner, F., Henderson, D. A., Arita, I., Jezek, Z. & Ladnyi, I. (1988) Smallpox and Its Eradication (W.H.O., Geneva).
4. Birmingham, K. & Kenyon, G. (2001) Nat. Med. 7, 1167.
5. Rosenthal, S. R., Merchlinsky, M., Kleppinger, C. & Goldenthal, K. L. (2001) Emerg. Infect. Dis. 7, 920-926.
6. Henderson, D. A. & Moss, B. (1999) in Vaccines, eds. Plotkin, S. A. & Orenstein, W. A. (Saunders, Philadelphia), pp. 74-97.
7. Freed, E. R., Duma, R. J. & Escobar, M. R. (1972) Am. J. Med. 52, 411-420.
8. Karupiah, G., Buller, R. M. L., Vanrooijen, N., Duarte, C. J. & Chen, J. H. (1996) J. Virol. 70, 8301-8309.
9. Demkowicz, W. E., Jr., Littaua, R. A., Wang, J. & Ennis, F. A. (1996) J. Virol. 70, 2627-2631.
10. Moss, B. & Earl, P. L. (1991) in Current Protocols in Molecular Biology, eds. Ausubel, F. M., Brent, R., Kingston, R., Moore, D., Seidman, J., Smith, J. & Struhl, K. (Wiley, New York), pp. 16.16.1-16.16.7.
11. Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A. & Stevanovic, S. (1999) Immunogenetics 50, 213-219.
12. Drexler, I., Antunes, E., Schmitz, M., Wolfel, T., Huber, C., Erfle, V., Rieber, P., Theobald, M. & Sutter, G. (1999) Cancer Res. 59, 4955-4963.
13. Pascolo, S., Bervas, N., Ure, J. M., Smith, A. G., Lemonnier, F. A. & Perarnau, B. (1997) J. Exp. Med. 185, 2043-2051.
14. Vabulas, R. M., Pircher, H., Lipford, G. B., Hacker, H. & Wagner, H. (2000) J. Immunol. 164, 2372-2378.
15. Alcami, A. & Smith, G. L. (1996) Proc. Natl. Acad. Sci. USA 93, 11029-11034.
16. Meyer zum Büschenfelde, C., Metzger, J., Hermann, C., Nicklisch, N., Peschel, C. & Bernhard. H. (2001) J. Immunol. 167, 1712-1219.
17. Knabel, M., Franz, T. J., Schiemann, M., Wulf, A., Villmow, B., Schmidt, B., Bernhard, H., Wagner, H. & Busch, D. H. (2002) Nat. Med. 8, 631-637.
18. Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E. & Greenberg, P. D. (1992). Science 257, 238-241.
19. Goebel, S. J., Johnson, G. P., Perkus, M. E., Davis, S. W., Winslow, J. P. & Paoletti, E. (1990) Virology 179, 247-266.
20. Massung, R. F., Liu, L.-I., Qi, J., Knight, J. C., Yuran, T. E., Kerlavage, A. R., Parsons, J. M., Venter, J. C. & Esposito, J. J. (1994) Virology 201, 215-240.
21. Rodriguez, J. F., Paez, E. & Esteban, M (1987) J. Virol. 61, 395-404.
22. Zinoviev, V. V., Tchikaev, N. A., Chertov, O. Y. & Malygin, E. G. (1994) Gene 147, 209-214.
23. Bronte, V., Carroll, M. W., Goletz, T. J., Wang, M., Overwijk, W. W., Marincola, F., Rosenberg, S. A., Moss, B. & Restifo, N. P. (1997) Proc. Natl. Acad. Sci. USA 94, 3183-3188.
24. da Fonseca, F. G., Wolffe, E. J., Weisberg, A. & Moss, B. (2000) J. Virol. 74, 7508-7517.
25. Lee, H. J., Essani, K. & Smith, G. L. (2001) Virology 281, 170-192.
26. Herrlich, A. & Mayr, A. (1957) Arch. Gesamte Virusforsch. 7, 284-296.
27. Mayr, A., Hochstein-Mintzel, V. & Stickl, H. (1975) Infection 3, 6-14.
28. Sutter, G. & Moss, B. (1992) Proc. Natl. Acad. Sci. USA 89, 10847-10851.
29. Sutter, G., Wyatt, L. S., Foley, P. L., Bennink, J. R. & Moss, B. (1994) Vaccine 12, 1032-1040.
30. Meyer, H., Sutter, G. & Mayr, A. (1991) J. Gen. Virol. 72, 1031-1038.
31. Lee, M., Roos, J., McGuigan, L., Smith, K., Cormier, N., Cohen, L., Roberts, B. & Payne, L. (1992) J. Virol. 66, 2617-2630.
32. Hirsch, V., Fuerst, T., Sutter, G., Carroll, M., Yang, L., Goldstein, S., Piatak, M., Elkins, W., Alvord, G., Montefiori, D., Moss, B. & Lifson, J. (1996) J. Virol. 70, 3741-3752.
33. Gierynska, M., Kumaraguru, U., Eo, S. K., Lee, S., Krieg, A. & Rouse, B. T. (2002) J. Virol. 76, 6568-6576.